Skip to main content

Month: March 2025

NEXE Innovations Makes Fifth Delivery to U.S.-Based EKOCUPS

The order replenishes existing SKUs, and NEXE is working on new blends for EKOCUPS to enhance its product offerings WINDSOR, Ontario, March 13, 2025 (GLOBE NEWSWIRE) — NEXE Innovations Inc. (“NEXE”, the “Company”, “we” or “our”) (TSX.V: NEXE) (Frankfurt: NX5) (OTC: NEXNF), a compostable and innovative materials company, is pleased to announce the completion of its fifth delivery to EKOCUPS. NEXE is also working with EKOCUPS to develop new blends and product offerings. EKOCUPS (https://ekocups.com/) is a well-established company based in the U.S. that sells its coffee products online, and it is a high-volume seller through Amazon. We believe this repeat order reinforces the durability and recurring nature of our revenues as we continue to strengthen our relationships with partners. In our view, increasing...

Continue reading

Integral Metals Commences Phase I Exploration at Woods Creek Project in Partnership with Big Rock Exploration

Integral Metals and Big Rock Exploration Move Forward with Rare Earth and Gallium Targeting at Woods Creek Project CALGARY, Alberta, March 13, 2025 (GLOBE NEWSWIRE) — Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the commencement of Phase I exploration on its Woods Creek Project in Montana. The program will be carried out in partnership with Big Rock Exploration (“BRE”), a leading geological consulting firm specializing in mineral exploration. The Woods Creek Project, located in a structurally complex shear zone, is considered prospective for rare earth elements (REEs) and gallium based on neighboring projects and regional geological indicators. With confirmed occurrences of rare earth elements in grab samples during prospecting in 2024, the presence of...

Continue reading

MAX Power Retains New Corporate Secretary

VANCOUVER, British Columbia, March 13, 2025 (GLOBE NEWSWIRE) — MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) (“MAX Power” or the “Company”) is pleased to announce that it has engaged Ms. Monita Faris as the Company’s new Corporate Secretary. Based in Vancouver, Ms. Faris is a seasoned industry professional with over 25 years of corporate governance, corporate secretarial, and securities regulation experience. She has served in several senior management and executive roles for companies listed on the Toronto Stock Exchange, TSX Venture Exchange, and the CSE. MAX Power has not renewed the contract of Mr. Rav Mlait who has been serving in a Corporate Development role since November 2024 (refer to Nov. 7, 2024 news release). Mr. Mansoor Jan, MAX Power CEO, commented: “Rav was MAX Power’s founding CEO and successfully...

Continue reading

Columbus Acquisition Corp Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on March 17, 2025

New York, March 13, 2025 (GLOBE NEWSWIRE) —  Columbus Acquisition Corp (the “Company”) (Nasdaq: COLA), a blank check company, today announced that, commencing on March 17, 2025, holders of 6,000,000 units (the “Units”) sold in the Company’s initial public offering (the “Offering”), may elect to separately trade the ordinary shares and rights included in the Units. Any Units not separated will continue to trade on the NASDAQ Global Market (“NASDAQ”) under the symbol “COLAU.” Any underlying ordinary shares and rights that are separated will trade on the NASDAQ under the symbols “COLA” and “COLAR,” respectively. Holders of Units will need to have their brokers contact the Company’s transfer agent, Continental Stock Transfer & Trust Company, in order to separate the holders’ Units into ordinary shares and rights. The Units were...

Continue reading

Blum Holdings Inc. Reports Remarkable 2024 Financial Results with $33.1 Million in Net Income

DOWNEY, Calif., March 13, 2025 (GLOBE NEWSWIRE) — Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company and cannabis operator, announced its financial results for the year ended December 31, 2024, marking the completion of a significant financial and operational transformation. Key Highlights from Fiscal Year 2024:Net Income: $33.1 million, representing an astonishing turnaround from a net loss of $14.1 million in 2023 and a net loss of $188.7 million in 2022, reflecting the successful restructuring and cost optimization efforts.Liability Reduction: Decreased by 62% to $29.6 million in 2024, from $77.8 million in 2023 and $125.3 million at the beginning of 2022, reflecting effective balance sheet management and successful restructuring strategies...

Continue reading

LiveOne (Nasdaq: LVO) to Participate in the 37th Annual ROTH Conference

LiveOne will host a VIP shareholder update on March 17th at 5:00pm PT at the Montage Hotel Laguna Beach Exclusive Shareholder Meeting Topics Include:Updated revenue model Insights into LiveOne’s M&A strategy and B2B partnerships Details on the restructuring of the company’s balance sheet and expected cost savings of over $30 million Update on acquisition of 400,000 additional shares and intended acquisition of 450,000 shares of PodcastOne (Nasdaq: PODC)LOS ANGELES, March 13, 2025 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment, and technology platform, announced today that it will participate in the upcoming 37th Annual ROTH Conference at the Laguna Cliffs Marriott Resort & Spa in Dana Point, CA, on March 16-18, 2025. LiveOne’s Chairman and CEO, Robert Ellin, will be...

Continue reading

BIO-key Partners with California Ed Tech JPA to Make its Identity and Access Management Solutions Available to 195 Member Institutions Serving Over 2.6M Students

– BIO-key’s PortalGuard Solution Delivers SecureMulti-Factor Authentication without Requiring Phones or Tokens – FRESNO, Calif. and HOLMDEL, N.J., March 13, 2025 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software for phoneless, tokenless, passwordless, and phishing-resistant authentication experiences, announced today a new partnership and Joint Purchase Agreement (JPA) with California’s Education Technology Joint Powers Authority (Ed Tech JPA), an alliance of 195 K-12 schools and school districts serving over 2.6 million students. BIO-key’s PortalGuard Platform was accepted as an approved identity management solution by the Ed Tech JPA following an extensive Request for Proposal (RFP) and review process. Considering...

Continue reading

COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product

No significant clinical adverse event observed in Phase 1clinical study Pharmacokinetic profile established and range of doses selected for Phase 2a Clinical Efficacy Study First patient expected to be treated in the Phase 2a Clinical Efficacy Study on March 14, 2025 at the Montreal Heart InstituteTORONTO, ONTARIO, March 13, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today announced Initiation of its Phase 2a clinical efficacy study of its flagship avenanthramides product being developed for potential applications in managing conditions related to inflammation. Avenanthramides are di-phenolic compounds found exclusively in...

Continue reading

Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform

Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, previously announced the initiation of preclinical studies for intranasal Naloxone, a life-saving opioid overdose treatment. As previously announced, the study will be conducted in collaboration with Professor Fabio Sonvico, Associate Professor at the Department of Food and Drug of the University of Parma (Italy) a leading expert in the development of intranasal and pulmonary drug delivery solutions and a member of the Company’s Scientific Advisory Board. These preclinical studies mark a step forward in evaluating Polyrizon’s Trap and Target™ (T&T) platform for the intranasal...

Continue reading

ZenaTech Expands ZenaDrone Team by 35 Engineers and Technicians to Meet Drone Production Manufacturing Capacity

VANCOUVER, British Columbia, March 13, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, announces today that its subsidiary ZenaDrone is expanding its team of drone engineers, technicians, and R&D engineers by adding 35 new hires to meet production line and capability requirements for the manufacturing of its drone products. “As we transition from the prototype stages to full-scale production of our drones, we are adding qualified engineering, manufacturing and technical talent to commence and accelerate full-scale manufacturing and assembly. Expanding our production line capacity by adding these resources is a critical step...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.